Swift Outpatient Alternatives for Rapid Stabilization (SOARS)
- Institution
- University of Washington, WA
- Principal investigator
- Molly Adrian
- Funding
- $1.0M
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
Suicide is a leading cause of death for youth and prevention efforts embedded in healthcare systems have promise for reducing this substantial public health problem. There is a significant gap between the expectations of a suicide care pathway and existing capacity and could be improved with optimized intervention packages that address key stakeholders- youth, patient, behavioral health providers, and outpatient medical providers- needs. Building upon promising pilot results, this project seeks to evaluate components of the Swift Outpatient Alternative for Rapid Stabilization (SOARS) intervention to build the strongest combination to reduce youth suicidal thoughts and behaviors (STB; Aim 1). We will test the impact patient characteristics (Aim 2) and if SOARS components function through their putative mechanisms. The optimized treatment package will be refined through co-design with providers to augment its acceptability and usability (Aim 4). Results will be used to create an optimized intervention package to accelerate the pace of adoption by healthcare systems and reduction of youth STBs. This will result in a youth suicide care intervention package optimized for ecological validity, effectiveness and efficiency, and ready for evaluation in a hybrid implementation trial.
LOADING MOONBASE SCORE
Questions for University of Washington
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Seattle Children's HospitalReviewed
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
Molly Adrian · $1.0M · 2021–2027
- NIH · University of WashingtonNot yet scored
Methods Core
Molly Adrian · $604K · 2023–2028
- NIH · University of Washington66
NextGen Long-acting and targeted combination ART for Children with HIV
Rodney J.Y. Ho · $1.4M · 2020–2026